Avacta Group plc (LON:AVCT) CEO Alastair Smith joins us to discuss its update on the lateral flow rapid antigen test. Alastair reminds us of the COVID-19 tests that it is developing,
Avacta Group plc (LON:AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISIONTM platforms, has announced significant progress in the development of a highly scalable manufacturing process for
The finalists in the 2020 Cambridge Independent Science and Technology Awards can now be revealed. Following hundreds of entries, a shortlist across 14 categories has been drawn up. Biotech Company of the
Avacta is supporting global efforts in combating the COVID-19 pandemic by using its Affimer® platform to develop diagnostic reagents for COVID-19 ANTIGEN testing. Avacta has generated a large number of
Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in
Cytiva launches new services for diagnostic developers and will establish new labs to meet the future needs of the industry. Cytiva Diagnostic Services will help developers bring point-of-care diagnostic tests to market quicker
The Wetherby-based firm hopes to get the test, which works like a pregnancy test but uses saliva, validated before the end of 2020, which could be a game changer for
Wouldn’t it be great to have a test for Covid-19 that’s as simple as a home pregnancy kit? Instead of weeing on it, you spit and it gives you an
Avacta said is continuing to work with the UK government’s CONDOR programme to obtain regulatory approval in the UK to use the test for diagnostic purposes too. The bead-assisted mass spectrometry (‘BAMS’)
Avacta Group’s CEO predicts a “transformational year” ahead with “momentous milestones” for the company as it progresses its Covid-19 test and other products. The Whittlesford-based drug development company unveiled interim
© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
